Summary
Bioorganic Research and Services SA (Bionaturis) is a biopharmaceutical company that develops biological drugs using FLYLIFE proprietary system. The company develops and manufactures drugs for human and animals such as poultry and swine, dogs, cats, salmonids, cattle, rabbits, and horses. Its product portfolio includes BNT001 and BNT014 for humans, BNT004, BNT005, BNT006, BNT007, BNT020, BNT022 and BNT013 among others for cattle and other animals. The company provides products in the form of vaccines, oral delivery and supplement. Its target treatment areas include gaucher disease, infectious diseases, fever, cancer, osteoarthritis and infertility among others.
GlobalData's Bioorganic Research and Services SA (BNT) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.
Bioorganic Research and Services SA Key Recent Developments:
Jul 02,2015: Bionaturis signs a strategic agreement for its corporate expansion in China
Jun 18,2015: Bionaturis and the US-Biotech company BMI sign an agreement for the jointly development of human and animal vaccines
May 01,2015: Bionaturis Group increased 29% EBITDA in full year 2014 results
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
